Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Isoprinosine Workflows for HSV-1 Research
2026-08-24
Isoprinosine, or inosine pranobex, supports a two-layer antiviral workflow that separates immune modulation from herpesvirus nuclear egress. This guide combines formulation controls, CLCC1-focused imaging, infectious-titer measurements, and troubleshooting for more interpretable HSV-1 experiments.
-
SU 5402 Workflows for RTK Signaling Research
2026-08-24
Build cleaner receptor tyrosine kinase experiments with SU 5402, from rapid phospho-ERK1/2 measurements to longer-term cell cycle and apoptosis assays. The same controlled perturbation strategy can be cautiously extended to human iPSC-derived sensory-neuron models, while preserving clear boundaries between established evidence and exploratory use.
-
AL-8810 Workflows for FP Receptor Signaling
2026-08-23
AL-8810 provides a reversible pharmacological route to dissect PGF2α/FP receptor biology across endometrial, vascular, ocular, and smooth-muscle models. This workflow-focused guide connects receptor antagonism with ERK1/2, MMP-2, vascular permeability, and tissue-remodeling readouts while emphasizing controls and troubleshooting.
-
Cholesterol–Fzd5 Coupling in Wnt-Driven Cancer
2026-08-22
The reference study identifies Fzd5 as a cholesterol-sensing Wnt receptor whose extracellular linker controls palmitoylation, receptor maturation, and signaling in pancreatic ductal adenocarcinoma. Its findings connect lipid metabolism with Wnt/β-catenin pathway dependence and suggest that competition at the Fzd5–cholesterol interface may have therapeutic relevance.
-
RepSox ALK5 Inhibitor for iPSC Platelet Workflows
2026-08-22
Learn how RepSox can be positioned as a controlled TGF-β pathway variable alongside an optimized hiPSC-to-platelet workflow. The article separates validated platelet-production advances from RepSox-specific hypotheses, with practical dosing screens, readouts, and troubleshooting guidance.
-
Peroxynitrite, Ca2+ Flux, and Cardiac I/R Injury
2026-08-21
Liu et al. identify an ONOO−-ER stress-IP3R-Ca2+ axis that links hyperhomocysteinemia to mitochondrial overload and necroptosis in cardiac microvascular endothelial cells during ischemia-reperfusion. The study also shows that pharmacological inhibition of IP3R-mediated Ca2+ release improves cardiac injury in hyperhomocysteinemic rats, providing a mechanistic framework for cell death pathway research.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-08-20
This 2024 ACS Biomaterials Science & Engineering study clarifies how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Using a mucosal in vitro model and inhibitor profiling, it identifies energy-dependent uptake, with macropinocytosis and caveolae-mediated endocytosis as dominant contributors, while clathrin-mediated uptake appears partial and phagocytosis negligible under the tested conditions.
-
HotStart 2X Green qPCR Master Mix for HCC
2026-08-20
HotStart 2X Green qPCR Master Mix supports SYBR Green qPCR workflows for gene expression analysis and nucleic acid quantification. Its antibody-mediated Taq polymerase hot-start inhibition helps limit pre-cycling nonspecific amplification, while assay controls and melt-curve analysis remain necessary for defensible HCC pathway measurements.
-
Mianserin HCl: Applied Research Workflows
2026-08-19
Mianserin HCl combines noradrenergic activity with 5-HT2 receptor antagonism, making it useful for receptor signaling, antidepressant, and psychiatric disorder research. This guide translates its reported pharmacology, cyclodextrin complexation, and antipathogenic findings into controlled bench workflows with practical troubleshooting strategies.
-
DAPT (GSI-IX) in Hepatobiliary Organoid Research
2026-08-19
DAPT (GSI-IX) provides a practical way to perturb γ-secretase-dependent Notch signaling in human hepatobiliary organoids while monitoring both lineage decisions and liver-specific function. This workflow connects a defined small-molecule intervention with the hiPSC organoid platform described in the reference study, supporting mechanistic, disease-modeling, and drug-development experiments.
-
Localized BDNF Release in Early NMJ Assembly
2026-08-18
The reference study shows that muscle-derived BDNF is not released uniformly: it is trafficked to podosome-like structures, processed, and secreted locally to organize early acetylcholine receptor clusters at developing neuromuscular junctions. By combining live-cell imaging, targeted perturbations, and muscle-specific BDNF knockout mice, the work connects spatial signaling with the earliest stages of postsynaptic assembly.
-
Perphenazine: Practical Research Workflows
2026-08-18
Perphenazine is a well-characterized dopamine D2 receptor antagonist for connecting receptor pharmacology with mitochondrial, neuronal, and macrophage assays. This guide translates its reported effects into practical workflows for mitochondria-mediated cell death induction, host-directed antibacterial studies, and mechanism-focused neuropharmacology research.
-
PGF2α/PTGFR Controls Endometrial Breakdown via HIF-1α
2026-08-17
A 2024 study identifies PGF2α signaling through PTGFR as a major regulator of endometrial shedding and vascular permeability in a mouse menstrual-like model. Its combination of receptor antagonism, HIF-1α inhibition, vascular readouts, and promoter-binding analysis supports a mechanistic HIF-1α–PTGFR–VEGF axis while highlighting important limits on translation to human menstruation.
-
2-D08: Selective Protein Sumoylation Inhibition
2026-08-17
2-D08, also called 2’,3’,4’-trihydroxyflavone, is a small-molecule inhibitor of protein sumoylation that blocks SUMO transfer from UBC9 without blocking E1 activation or UBC9-SUMO thioester formation. Its reported use is limited to in vitro mechanistic studies, including topoisomerase I sumoylation inhibition in breast cancer cells.
-
BHQ for SERCA and Calcium Signaling Research
2026-08-16
BHQ gives researchers a practical way to perturb SERCA-dependent calcium storage, from acute calcium imaging to hematopoietic stem cell mobilization assays. This guide connects reagent handling, pathway-resolved readouts, vascular applications, and troubleshooting without treating a mechanistic research tool as a clinical intervention.